Weight loss and diabetes injections#medical_benefits 19

Studies on the impact of these medications in preventing heart and artery diseases in diabetic patients: https://pmj.bmj.com/content/96/1133/156 You will notice varying results. They are also included in medical guidelines for treating type 2 diabetes—see the chart in this link: https://diabetologia-journal.org/2018/10/05/new-easd-ada-consensus-guidelines-on-managing-hyperglycaemia-in-type-2-diabetes-launched-at-easd-meeting-new-recommendations-include-specific-drug-classes-for-some-patients-and-enhancing-medication-a/

Saxenda is administered once daily, while Ozempic and Trulicity are given once weekly. These injections should be refrigerated. The efficacy of Ozempic at a weekly dose of 1 mg is not significantly lower than Saxenda at 2.4 mg daily in many patients. There is an oral medication in the same group with the scientific name Semaglutide and the commercial name Rybelsus, but it is not highly effective for weight loss. If the goal is weight loss and the person is not diabetic, diet modification and exercise are undoubtedly better options. Starting these injections just before or during Ramadan is not recommended for those not already using them, to avoid dehydration. Nausea may occur at the beginning of treatment with these medications or when increasing the dose, which can be managed with standard anti-nausea drugs.